Cerebrovascular glycocalyx damage and microcirculation impairment in patients with temporal lobe epilepsy
- PMID: 37231664
- PMCID: PMC10581235
- DOI: 10.1177/0271678X231179413
Cerebrovascular glycocalyx damage and microcirculation impairment in patients with temporal lobe epilepsy
Abstract
Temporal lobe epilepsy (TLE) is increasingly associated with blood-brain barrier dysfunction and microvascular alterations, yet the pathophysiological link is missing. An important barrier function is exerted by the glycocalyx, a gel-like layer coating the endothelium. To explore such associations, we used intraoperative videomicroscopy to quantify glycocalyx and microcirculation properties of the neocortex and hippocampus of 15 patients undergoing resective brain surgery as treatment for drug-resistant TLE, and 15 non-epileptic controls. Fluorescent lectin staining of neocortex and hippocampal tissue was used for blood vessel surface area quantification. Neocortical perfused boundary region, the thickness of the glycocalyx' impaired layer, was higher in patients (2.64 ± 0.52 µm) compared to controls (1.31 ± 0.29 µm), P < 0.01, indicative of reduced glycocalyx integrity in patients. Moreover, erythrocyte flow velocity analysis revealed an impaired ability of TLE patients to (de-)recruit capillaries in response to changing metabolic demands (R2 = 0.75, P < 0.01), indicating failure of neurovascular coupling mechanisms. Blood vessel quantification comparison between intraoperative measurements and resected tissue showed strong correlation (R2 = 0.94, P < 0.01). This is the first report on in vivo assessment of glycocalyx and microcirculation properties in TLE patients, confirming the pivotal role of cerebrovascular changes. Further assessment of the cerebral microcirculation in relation to epileptogenesis might open avenues for new therapeutic targets for drug-resistant epilepsy.
Keywords: Blood-brain barrier; capillary recruitment; glycocalyx; microcirculation; temporal lobe epilepsy.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: HV is the Chief Science Officer at GlycoCheck & Microvascular Health Solutions. The authors declare that this manuscript has not been or currently is under review by any other journal.
Figures
References
-
- World Health Organization W. Epilepsy Factsheet no 999, www.who.int/en/news-room/fact-sheets/detail/epilepsy (2018, accessed 28 October 2022).
-
- Laxer KD, Trinka E, Hirsch LJ, et al.. The consequences of refractory epilepsy and its treatment. Epilepsy Behav 2014; 37: 59–70. - PubMed
-
- Beghi E. Addressing the burden of epilepsy: many unmet needs. Pharmacol Res 2016; 107: 79–84. - PubMed
-
- Wiebe S, Blume W, Girvin J, et al.. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345: 311–318. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
